Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115470937 | 11547093 | 7 | F | 20150915 | 20160811 | 20150924 | 20160820 | EXP | CN-ASTRAZENECA-2015SE91353 | ASTRAZENECA | 16577.00 | DY | F | Y | 0.00000 | 20160820 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115470937 | 11547093 | 1 | PS | SAXAGLIPTIN | SAXAGLIPTIN | 1 | Oral | 575 | MG | Y | 0 | 5 | MG | TABLET | QD | ||||
| 115470937 | 11547093 | 2 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | Y | 0 | TABLET | |||||||||
| 115470937 | 11547093 | 3 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | Y | 0 | TABLET | |||||||||
| 115470937 | 11547093 | 4 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | Y | 0 | TABLET | |||||||||
| 115470937 | 11547093 | 5 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | Y | 0 | TABLET | |||||||||
| 115470937 | 11547093 | 6 | C | ACARBOSE. | ACARBOSE | 1 | Oral | 0 | 50 | MG | TABLET | TID | |||||||
| 115470937 | 11547093 | 7 | C | SHUXUETONG | 2 | Intravenous (not otherwise specified) | 0 | 6 | ML | INJECTION | BID | ||||||||
| 115470937 | 11547093 | 8 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 0 | 40 | MG | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115470937 | 11547093 | 1 | Type 2 diabetes mellitus |
| 115470937 | 11547093 | 2 | Type 2 diabetes mellitus |
| 115470937 | 11547093 | 3 | Type 2 diabetes mellitus |
| 115470937 | 11547093 | 4 | Type 2 diabetes mellitus |
| 115470937 | 11547093 | 5 | Type 2 diabetes mellitus |
| 115470937 | 11547093 | 6 | Type 2 diabetes mellitus |
| 115470937 | 11547093 | 7 | Haemostasis |
| 115470937 | 11547093 | 8 | Prophylaxis against gastrointestinal ulcer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115470937 | 11547093 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115470937 | 11547093 | Cerebral infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115470937 | 11547093 | 1 | 20150521 | 20150912 | 0 | |
| 115470937 | 11547093 | 2 | 20150521 | 20150610 | 0 | |
| 115470937 | 11547093 | 3 | 20150611 | 20150624 | 0 | |
| 115470937 | 11547093 | 4 | 20150625 | 20150708 | 0 | |
| 115470937 | 11547093 | 5 | 20150709 | 20150912 | 0 | |
| 115470937 | 11547093 | 6 | 20150915 | 20150924 | 0 | |
| 115470937 | 11547093 | 7 | 20150915 | 20150923 | 0 | |
| 115470937 | 11547093 | 8 | 20150915 | 20150917 | 0 |